Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (601-610 of 1,095) with videos related to

Pageof 110
Sort By:
American Journal of Physical Anthropology|April 11, 2018
The physiological linkage between molar inclination and dental macrowear patternGregorio Oxilia, Eugenio Bortolini, Sergio Martini, et al.
Biochemical Pharmacology|June 29, 2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatmentsClaudia Fumarola, Silvia La Monica, Mara Bonelli, et al.
European Urology Oncology|August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysisCarlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLCGiulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
Plos One|July 1, 2016
Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta InfectionMaria Homs, Francisco Rodriguez-Frias, Josep Gregori, et al.
Plos One|July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Immunotherapy|September 16, 2020
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapyMelissa Bersanelli, Teresa Zielli, Fabiana Perrone, et al.
Diagnostics (Basel, Switzerland)|February 11, 2023
The Role of CT Imaging in Characterization of Small Renal MassesMaria Vittoria Bazzocchi, Carlotta Zilioli, Vita Ida Gallone, et al.
Surgery|October 22, 2023
From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablationMohammad Hussein, Eman Toraih, Peter P Issa, et al.
Acta Bio-Medica : Atenei Parmensis|January 8, 2020
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumabMelissa Bersanelli, Letizia Gnetti, Augusto Vaglio, et al.
Pageof 110

Showing results (601-610 of 1,095) with videos related to

Sort By:
Pageof 110
American Journal of Physical Anthropology|April 11, 2018
The physiological linkage between molar inclination and dental macrowear patternGregorio Oxilia, Eugenio Bortolini, Sergio Martini, et al.
Biochemical Pharmacology|June 29, 2024
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatmentsClaudia Fumarola, Silvia La Monica, Mara Bonelli, et al.
European Urology Oncology|August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysisCarlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLCGiulia Mazzaschi, Francesco Facchinetti, Gabriele Missale, et al.
Plos One|July 1, 2016
Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta InfectionMaria Homs, Francisco Rodriguez-Frias, Josep Gregori, et al.
Plos One|July 19, 2016
An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)Tarik Asselah, Christophe Moreno, Christoph Sarrazin, et al.
Immunotherapy|September 16, 2020
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapyMelissa Bersanelli, Teresa Zielli, Fabiana Perrone, et al.
Diagnostics (Basel, Switzerland)|February 11, 2023
The Role of CT Imaging in Characterization of Small Renal MassesMaria Vittoria Bazzocchi, Carlotta Zilioli, Vita Ida Gallone, et al.
Surgery|October 22, 2023
From ablation to operation: Unraveling the surgical outcomes and complications of thyroidectomy after radiofrequency ablationMohammad Hussein, Eman Toraih, Peter P Issa, et al.
Acta Bio-Medica : Atenei Parmensis|January 8, 2020
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumabMelissa Bersanelli, Letizia Gnetti, Augusto Vaglio, et al.
Pageof 110